ibd
Federica Facciotti, from University of Milano Bicocca, focuses on how the gut microbiota interacts with immune activation, shaping both chronic inflammatory intestinal disorders and oncology, particularly colorectal cancer.
A gut bacterium, Clostridium steroidoreducens, can chemically modify steroid hormones, including those used to treat IBD.
Controlling cadaverine levels and the gut bacteria that produce it could help regulate immune cell metabolism and inflammation.
Philippe Langella, Research director at INRAE, talks about how F. prausnitzii could be a beneficial commensal.
Targeting the microbiota could be a new way to strengthen gut immunity and develop treatments for inflammatory bowel diseases such as Crohn’s disease.
By revealing that OTUD3 limits microbiota-driven STING activation, the findings of a new study offer insights into the disease mechanisms of ulcerative colitis and may pave the way to new…
Recent studies have identified various bacterial and fungal pathobionts in patients with CD and UC.
STING activity is important for gut health and that targeting this molecule could offer new treatments for IBD.
TCA can help to manage IBD by supporting the gut barrier and influencing microbiota composition.
Understanding the complex interactions between exercise, diet and gut health can help to develop approaches to influence the gut microbiota, boost immunity and prevent or manage gastrointestinal diseases.
